Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Iterum Therapeutics Plc
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Iterum Therapeutics Plc since year 2005.
Table 2 shows the detailed insider transactions of Iterum Therapeutics Plc since 2005.
The reporting company's ticker symbol is ITRM. The reporting company's CIK number is 1659323.
The total value of stock buying since 2005 is $57,372,989.
The total value of stock sales since 2005 is $0.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-11-30||Kelly David George (Director)||Buy||10,000||6.29||62,890|
|2018-10-30||Chin Mark (Director)||Buy||58,000||6.10||353,800|
|2018-09-04||Dunne Michael W. (Chief Scientific Officer)||Buy||500||10.00||5,000|
|2018-08-27||Dunne Michael W. (Chief Scientific Officer)||Buy||500||10.00||5,000|
|2018-08-24||Dunne Michael W. (Chief Scientific Officer)||Buy||500||10.00||5,000|
|2018-08-23||Edick Paul R (Director)||Buy||500||10.44||5,218|
|2018-08-17||Fishman Corey N. (President & CEO)||Buy||2,000||8.73||17,466|
|2018-05-30||Chin Mark (Director)||Buy||337,606||13.00||4,388,878|
|2018-05-30||Matthews Judith M. (Chief Financial Officer)||Buy||4,000||13.00||52,000|
|2018-05-30||Canaan Partners X Llc (Director)||Buy||506,656||13.00||6,586,528|
|2018-05-30||Fhm Vii, L.p. (10% Owner)||Buy||456,099||13.00||5,929,287|
|2018-05-30||Fishman Corey N. (President & CEO)||Buy||3,000||13.00||39,000|
|2018-05-30||Dunne Michael W. (Chief Scientific Officer)||Buy||2,000||13.00||26,000|
|2018-05-30||Ratcliffe Liam (10% Owner)||Buy||662,677||13.00||8,614,801|
|2018-05-30||Malik Shahzad (Director)||Buy||236,984||13.00||3,080,792|
|2018-05-30||Ahrens Brenton Karl (Director)||Buy||506,656||13.00||6,586,528|
|2018-05-30||Hunt Ronald (Director)||Buy||662,677||13.00||8,614,801|
|2018-05-30||Healy James (Director)||Buy||500,000||13.00||6,500,000|
Insider trading activities including stock purchases, stock sales, and option exercises of ITRM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Iterum Therapeutics Plc (symbol ITRM, CIK number 1659323) see the Securities and Exchange Commission (SEC) website.